These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13590775)

  • 41. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study.
    García-Erce JA; Cuenca J; Muñoz M; Izuel M; Martínez AA; Herrera A; Solano VM; Martínez F
    Vox Sang; 2005 May; 88(4):235-43. PubMed ID: 15877644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M; Uchiyama T; Okamoto S; Kanakura Y; Sawada K; Tomonaga M; Nakao S; Nakahata T; Harada M; Murate T; Ozawa K;
    Eur J Haematol; 2007 Jun; 78(6):487-94. PubMed ID: 17391310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multispectral quantitative magnetic resonance imaging of brain iron stores: a theoretical perspective.
    Jara H; Sakai O; Mankal P; Irving RP; Norbash AM
    Top Magn Reson Imaging; 2006 Feb; 17(1):19-30. PubMed ID: 17179894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron chelation therapy in sickle-cell disease and other transfusion-dependent anemias.
    Kwiatkowski JL; Cohen AR
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1355-77, ix. PubMed ID: 15511620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron metabolism and iron chelation in sickle cell disease.
    Walter PB; Harmatz P; Vichinsky E
    Acta Haematol; 2009; 122(2-3):174-83. PubMed ID: 19907155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iron, oxidative stress and human health.
    Puntarulo S
    Mol Aspects Med; 2005; 26(4-5):299-312. PubMed ID: 16102805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation-induced lysosomal iron reactivity: implications for radioprotective therapy.
    Persson HL
    IUBMB Life; 2006 Jul; 58(7):395-401. PubMed ID: 16801214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of blood transfusion on the iron content of human tissues].
    CZAJA H
    Patol Pol; 1958; 9(2):117-26. PubMed ID: 13590775
    [No Abstract]   [Full Text] [Related]  

  • 50. Iron chelation beyond transfusion iron overload.
    Pietrangelo A
    Am J Hematol; 2007 Dec; 82(12 Suppl):1142-6. PubMed ID: 17968974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ferritin as an iron concentrator and chelator target.
    Liu X; Theil EC
    Ann N Y Acad Sci; 2005; 1054():136-40. PubMed ID: 16339659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iron accumulation during cellular senescence.
    Killilea DW; Wong SL; Cahaya HS; Atamna H; Ames BN
    Ann N Y Acad Sci; 2004 Jun; 1019():365-7. PubMed ID: 15247045
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.